Anika Therapeutics (ANIK) Change in Taxes (2011 - 2026)
Anika Therapeutics (ANIK) posted quarterly Change in Taxes of -$65000.0 for Q2 2026, up 85.06% year-over-year from -$35124.2 in Q2 2025, and down 105.46% quarter-over-quarter from $1.2 million in Q1 2026.
Anika Therapeutics (ANIK) Change in Taxes (2011 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Change in Taxes for 16 consecutive years, with -$65000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Taxes rose 85.06% year-over-year to -$65000.0; the TTM figure through Jun 2026 stood at $1.4 million (up 62.05% YoY), while the FY2025 annual figure was -$134000.0, down 120.15% from the prior year.
- Change in Taxes fell to -$65000.0 in Q2 2026 per ANIK's latest filing, from $1.2 million in the prior quarter.
- Across five years, Change in Taxes topped out at $1.3 million in Q2 2022 and bottomed at -$761000.0 in Q2 2024.
- Historically, Change in Taxes has averaged $201277.8 across 5 years, with a median of $38500.0 in 2024.
- Annual changes were most pronounced in 2023 — Change in Taxes sank 130.96% — and 2026, when it soared 9253.85%.
- Anika Therapeutics' Change in Taxes stood at $1.0 million in 2022, then plunged by 58.38% to $422000.0 in 2023, then slumped by 77.01% to $97000.0 in 2024, then surged by 245.36% to $335000.0 in 2025, then plunged by 119.4% to -$65000.0 in 2026.
- Business Quant data shows ANIK's Change in Taxes at -$65000.0 in Q2 2026, $1.2 million in Q1 2026, and $335000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | -66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -106.03 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 40.90 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -59.60 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Anika Therapeutics | 285.93 Mn | 247.52 Mn | 21.24 Mn | -65,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -65,000.00 |
| Jun 30, 2026 | -65,000.00 |
| Mar 31, 2026 | 1.19 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 335,000.00 |
| Dec 31, 2025 | 335,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | -435,000.00 |
| Jun 30, 2025 | -435,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | -761,000.00 |
| Jun 30, 2024 | -761,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Mar 31, 2024 | 90,000.00 |